scholarly journals Nanobody-displaying porous silicon nanoparticles for the co-delivery of siRNA and doxorubicin

2021 ◽  
Vol 9 (1) ◽  
pp. 133-147
Author(s):  
Terence Tieu ◽  
Marcin Wojnilowicz ◽  
Pie Huda ◽  
Kristofer J. Thurecht ◽  
Helmut Thissen ◽  
...  

Targeted delivery of chemotherapeutics to cancer cells has the potential to yield high drug concentrations in cancer cells while minimizing any unwanted side effects.

RSC Advances ◽  
2015 ◽  
Vol 5 (55) ◽  
pp. 44660-44665 ◽  
Author(s):  
Bing Xia ◽  
Bin Wang ◽  
Wenyi Zhang ◽  
Jisen Shi

Styrene-terminated PSiNPs were fabricated for high loading of doxorubicin via π-stacking, which exhibited an excellent capability for killing cancer cells.


2019 ◽  
Vol 11 (37) ◽  
pp. 33637-33649 ◽  
Author(s):  
Meihua Luo ◽  
Guido Lewik ◽  
Julian Charles Ratcliffe ◽  
Chung Hang Jonathan Choi ◽  
Ermei Mäkilä ◽  
...  

2016 ◽  
Vol 4 (21) ◽  
pp. 3639-3642 ◽  
Author(s):  
Arnaud Chaix ◽  
Khaled El Cheikh ◽  
Elise Bouffard ◽  
Marie Maynadier ◽  
Dina Aggad ◽  
...  

Porous silicon nanoparticles grafted with a mannose-6-phosphate analogue were designed for targeting prostate cancer cells.


2016 ◽  
Vol 6 (3) ◽  
pp. 1601009 ◽  
Author(s):  
Zehua Liu ◽  
Vimalkumar Balasubramanian ◽  
Chinmay Bhat ◽  
Mikko Vahermo ◽  
Ermei Mäkilä ◽  
...  

2021 ◽  
Author(s):  
Byungji Kim ◽  
Qinglin Yang ◽  
Leslie W. Chan ◽  
Sangeeta N. Bhatia ◽  
Erkki Ruoslahti ◽  
...  

RNAi-mediated immunotherapy provided by fusogenic porous silicon nanoparticles demonstrates superior therapeutic efficacy against both Gram-positive and Gram-negative bacterial infections compared with first-line antibiotics.


Sign in / Sign up

Export Citation Format

Share Document